1.3 C
New York
Tuesday, January 31, 2023

Intuitive Surgical Inc. (NASDAQ: ISRG) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Intuitive Surgical Inc. (ISRG) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.34, or 0.13%, to $260.30. The Intuitive Surgical Inc. has recorded 93,981 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Intuitive Announces Preliminary Fourth Quarter and Full Year 2022 Results.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Stocks Info

The company is listed on the NASDAQ and operates within the Medical Instruments & Supplies industry segment. At the end of the last regular session, the stock closed at $259.96 and fluctuated between $265.49 as its day high and $254.64 as its day low. The current market capitalization of Intuitive Surgical Inc. is $91.26B. A total of 3.51 million shares were traded on the day, compared to an average of 2.16M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ISRG has seen 6 BUY and 6 SELL insider trades, representing the acquisition of 89,875 and the disposition of 66,578 shares. Over the last 12 months, there were 68 BUYs and 62 SELLs from insiders. Insiders purchased 326,578 shares during that period but sold 217,365.

In the most recent transaction, Johnson Amal M sold 6,375 shares of ISRG for 239.36 per share on Nov 08. After the transaction, the Director now owns 11,224 company shares. In a previous transaction on Nov 01, Curet Myriam sold 8,000 shares at 250.06 per share. ISRG shares that EVP & Chief Medical Officer owns now total 217.

Among the insiders who sold shares, GUTHART GARY S disposed of 44,203 shares on Oct 21 at a per-share price of $210.84. This resulted in the President & CEO holding 23,297 shares of ISRG after the transaction. In another insider transaction, Curet Myriam sold 8,000 shares at $209.78 per share on Oct 21. Company shares held by the EVP & Chief Medical Officer now total 217.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ISRG in the last 3 months, the mean price target is $284.11 with high estimates of $325.00 and low estimates of $215.00. In terms of 52-week highs and lows, ISRG has a high of $328.16 and a low of $180.07.

As of this writing, ISRG has an earnings estimate of $1.25 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of $1.32 per share and a lower estimate of $1.14. The company reported an EPS of $1.14 in the last quarter, which was -4.20% lower than expectations of $1.19.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ISRG is Sell with a score of 4.33. A total of 11 analysts rated the stock as Buy while 3 rated it as Overweight while 10 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles